Munich Area, Germany
Founder & Chief Executive Officer at Volvox Therapeutics (parttime)
Pharmaceuticals
Education
Frankfurt School of Finance & Management 1999 — 1999
Albert-Ludwigs-Universität Freiburg im Breisgau 1979 — 1984
M.D.
Glasgow Medical School 1982 — 1983
M.B, Ch.B.
RWTH Aachen 1977 — 1979
cand.med.
Experience
Susavox Biotechnologies Inc. August 2014 - Present
Volvox Therapeutics December 2013 - Present
Fung Consulting Healthcare & Life Sciences July 2008 - Present
LifeScience Ventures October 2012 - April 2014
ERGOMED Group November 2007 - July 2008
Micromet AG November 2006 - November 2007
AstraZeneca UK January 2006 - October 2006
Novo Nordisk A/S 2003 - 2005
Pharmacia October 2001 - September 2003
Roche Pharmaceuticals 1997 - 2000
Skills
Development of..., Pharmaceuticals, Translational Medicine, Biotechnology, Immunology, Therapeutic Areas, R&D, Nephrology, Biopharmaceuticals, Transplant, Hematology, Health Economics, Project Portfolio..., Healthcare, Oncology, Translational Research, Pharmaceutical Industry, GCP, Hospital Sales, Pharmacology, Due Diligence, Monoclonal Antibodies, FDA, Infectious Diseases, Cancer, Medical Affairs, Market Access, CRO, Clinical Trials, Inflammation, Life Sciences, Portfolio Management, Pharma Valuation, Clinical, Transplantation, Clinical Pharmacology, Change Management, Lifesciences, Outcomes Research, Medicine, Clinical Research, Drug Development, Clinical Development, Autoimmune Diseases, Biologics, Internal Medicine